Trademark: 97638305
Word
EDIT
Status Date
Tuesday, May 7, 2024
Filing Date
Wednesday, October 19, 2022
Published for Opposition
Tuesday, September 19, 2023
5 Pharmaceutical preparations for the treatment and prevention of genetically driven disorders, neurological, gastrointestinal, metabolic, immunological, dyslipidemias musculoskeletal, oncological disorders and diseases of the retina, liver, heart, lung, bone marrow, brain, muscle, immune system, and kidney; reagents for medical and veterinary purposes being medical use; nucleic acid sequences and chemical reagents for medical and veterinary purposes; nucleic acid vectors comprising nucleotides for medical and veterinary purposes, namely, nucleic acid sequences and chemical reagents for medical and veterinary purposes
1 Reagents for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; nucleic acids for laboratory use for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; nucleotides for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; reagent kits comprised of reagents and chemical preparations for scientific research purposes; samples of nucleotide sequence variants and modifications for use in the fields of scientific research, clinical research, and scientific diagnostics research, namely, nucleic acids for laboratory use
Oct 22, 2022
New Application Entered
Nov 3, 2022
New Application Office Supplied Data Entered
Jan 31, 2023
Assigned To Examiner
Feb 10, 2023
Non-Final Action Written
Feb 10, 2023
Non-Final Action E-Mailed
Feb 10, 2023
Notification Of Non-Final Action E-Mailed
Apr 15, 2023
Teas Change Of Owner Address Received
Apr 15, 2023
Teas Change Of Correspondence Received
Apr 15, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
May 10, 2023
Teas Response To Office Action Received
May 10, 2023
Correspondence Received In Law Office
May 10, 2023
Teas/Email Correspondence Entered
May 11, 2023
Final Refusal Written
May 11, 2023
Final Refusal E-Mailed
May 11, 2023
Notification Of Final Refusal Emailed
Aug 10, 2023
Teas Request For Reconsideration Received
Aug 11, 2023
Exparte Appeal Received At Ttab
Aug 11, 2023
Jurisdiction Restored To Examining Attorney
Aug 11, 2023
Ex Parte Appeal-Instituted
Aug 15, 2023
Examiners Amendment -Written
Aug 15, 2023
Examiners Amendment E-Mailed
Aug 15, 2023
Notification Of Examiners Amendment E-Mailed
Aug 15, 2023
Examiner's Amendment Entered
Aug 15, 2023
Approved For Pub - Principal Register
Aug 30, 2023
Notification Of Notice Of Publication E-Mailed
Sep 19, 2023
Published For Opposition
Sep 19, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 26, 2023
Exparte Appeal Dismissed As Moot
Oct 26, 2023
Exparte Appeal Terminated
Feb 28, 2024
Teas Change Of Correspondence Received
Nov 14, 2023
Noa E-Mailed - Sou Required From Applicant
Feb 28, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 28, 2024
Teas Change Of Owner Address Received
May 7, 2024
Sou Teas Extension Received
May 7, 2024
Sou Extension 1 Filed
May 7, 2024
Sou Extension 1 Granted
May 8, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
